D-0391-2021 Class III Terminated

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ

FDA drug recall D-0391-2021 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on May 7, 2021 and is designated Class III. Reason for recall: Subpotent and Presence of Particulates . The recall status is terminated (terminated Jun 17, 2022).

Recall details

Product Type
Drugs
Report Date
May 26, 2021
Initiation Date
May 7, 2021
Termination Date
Jun 17, 2022
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 NDC 47335-506-96

Reason for recall

Subpotent and Presence of Particulates .

Distribution pattern

Nationwide in the US

Code information

Lot # 10009, exp. date 03/2022 10006, exp. date 01/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0391-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0391-2021. Report a data issue: hello@regdatalab.com.